GSTM1 and anemia (phenotype): As our systematic review showed the strongest association between anemia and poor SAH outcome at Hb values between 9.0 and 10.0 g/dL, this Hb range might present an appropriate Hb threshold justifying RBCT in SAH patients at high risk of cerebral ischemia and poor outcome.